TerrAscend (STU:TED) Moat Score: 2/10 (As of Jun. 25, 2026)


STU:TED TerrAscend Corp STU:TED
38 GF Score
Price €0.56
GF Value €0.85
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is TerrAscend Moat Score?

TerrAscend STU:TED +3.15% 38 Moat Score is 2 as of Jun. 25, 2026. GuruFocus rates STU:TED with a GF Score™ of 38/100 and a GF Value™ of €0.85 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 1,033 Drug Manufacturers companies, TerrAscend ranks better than 81.7% on this metric.

TerrAscend has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

TerrAscend has No Moat: TerrAscend operates in the cannabis industry, which is highly competitive and fragmented. The company lacks significant market leadership, customer loyalty, or proprietary technology, resulting in a very weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes TerrAscend might have No Moat - Very weak/transient advantages.

TerrAscend  (STU:TED) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

TerrAscend Moat Score Related Terms

STU:TED vs ZTS: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TerrAscend's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TerrAscend Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TerrAscend's Moat Score distribution charts can be found below:

* The bar in red indicates where TerrAscend's Moat Score falls into.


STU:TED
38GF Score
TerrAscend Corp STU:TED
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
TerrAscend (STU:TED) has a Moat Score of 2 as of Jun. 25, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, TerrAscend ranks #189 out of 1033 companies in the Drug Manufacturers industry, placing it in the top 18.3%.
Is TerrAscend's Moat Score too high?
TerrAscend's current Moat Score is 2. Based on the distribution chart, TerrAscend ranks #189 out of 1033 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, TerrAscend has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TerrAscend's Moat Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, TerrAscend ranks #189 out of 1033 companies for Moat Score. This places TerrAscend in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. TerrAscend's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TerrAscend stock overvalued right now?
Based on GuruFocus' analysis, TerrAscend (STU:TED) is currently considered Possible Value Trap. The stock's GF Value™ is €0.85, compared to a current price of €0.56 — trading 34.5% below its estimated fair value. The current Moat Score is 2. TerrAscend's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For TerrAscend (STU:TED), the current Moat Score is 2 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TerrAscend (STU:TED) Overvalued in 2026?

Based on GuruFocus' analysis, TerrAscend stock appears to be undervalued. The current stock price of €0.56 is trading 34.5% below its estimated GF Value™ of €0.85. GuruFocus considers TerrAscend to be Possible Value Trap.

Key valuation signals for STU:TED:

  • Moat Score: 2
  • GF Value™: €0.85 vs. price of €0.56 (34.5% below fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the STU:TED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TerrAscend Business Description

Other Exchanges TSNDF:USATSND:Canada
Address 77 City Centre Drive, Suite 501, East Tower, Mississauga, ON, CAN, L5B 1M5
TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.
38GF Score

Get the complete analysis for STU:TED

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.56
Price
€0.85
GF Value